Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: A 20-year cohort study of 3.8 million vaccinees
Open Access
- 4 February 2014
- journal article
- viral hepatitis
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hepatology
- Vol. 60 (1), 125-132
- https://doi.org/10.1002/hep.27048
Abstract
Hepatitis B immunization has been documented to prevent fulminant hepatic failure (FHF) and hepatocellular carcinoma (HCC) by historical comparison studies in Taiwan. This study aimed to assess long-term risks and predictors of various liver diseases associated with incomplete immunization in 3.8 million vaccinees. Profiles of the National Hepatitis B Immunization Registry, National Cancer Registry, and National Death Certification Registry were linked to ascertain newly diagnosed cases of HCC and deaths from FHF and chronic liver diseases (CLDs) from infancy to early adulthood of 3,836,988 newborn vaccinees. Cox's proportional hazards models were used to estimate hazard ratios (HRs) for various risk predictors. There were 49 newly developed cases of HCC, 73 deaths from FHF, and 74 deaths from CLDs during the follow-up of 41,854,715 person-years. There were striking differences between unvaccinated and vaccinated newborns after the launch of a national immunization program for HCC incidence (0.293 vs. 0.117 per 100,000 person-years), FHF mortality (0.733 vs. 0.174 per 100,000 person-years), and CLD mortality (2.206 vs. 0.177 per 100,000 person-years). Among vaccinees, incomplete immunization was the most important risk predictor of HCC, FHF, and CLDs, showing an HR (95% confidence interval, P value) of 2.52 (1.25-5.05; P = 0.0094), 4.97 (3.05-8.11; P < 0.0001), and 6.27 (3.62-10.84; P < 0.0001), respectively, after adjustment for maternal hepatitis B serostatus. Conclusion: Hepatitis B immunization can significantly prevent the long-term risk of HCC, FHF, and CLDs from infancy to early adulthood. Incomplete immunization with hepatitis B immunoglobulin or vaccines was the most important risk predictor of the liver disease among vaccinees. (Hepatology 2014;60:125–132)Funding Information
- Academia Sinica
This publication has 32 references indexed in Scilit:
- Natural history of chronic hepatitis B REVEALedJournal of Gastroenterology and Hepatology, 2011
- Natural history of hepatitis B virus infection: pediatric perspectiveThe Esophagus, 2010
- Hepatitis B virus infectionThe Lancet, 2009
- Hepatitis B and pregnancy: an underestimated issueLiver International, 2009
- A mathematical model to estimate global hepatitis B disease burden and vaccination impactInternational Journal of Epidemiology, 2005
- Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: Multistage hepatocarcinogenesis with multifactorial etiologyJournal of Hepatology, 2002
- Hepatitis B e Antigen and the Risk of Hepatocellular CarcinomaThe New England Journal of Medicine, 2002
- Postnatal Infectivity of Hepatitis B Surface Antigen-Carrier MothersThe Journal of Infectious Diseases, 1983
- Incidence of Hepatitis B Virus Infections in Preschool Children in TaiwanThe Journal of Infectious Diseases, 1982
- Vertical Transmission of Hepatitis B Antigen in TaiwanThe New England Journal of Medicine, 1975